A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes (ACHIEVE-5)
Care, 2002, 5:66-74Carr, Am
c) agree not to use our website network Services for any military, nuclear, missile, chemical or biological weaponry end uses that would be a violation of the U.S
doi: 10.1091/mbc.E23-02-0042 34
Funding This work was supported by the National Natural Science Foundation of China [grant number 82074206], the Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission [grant number 21Y21920500] and Changhai Hospital Gu Hai plan
Insurance coverage remains inconsistent, motivating many individuals to explore self-pay options that offer lower monthly commitments